Back to resultsMean Arterial Pressure (MAP) and Renal Perfusion: Evaluation of Critically Ill Patients With Normal Creatinine or Reduced Renal Function
Primary Purpose
Kidney Failure, Acute
Status
Withdrawn
Phase
Not Applicable
Locations
Belgium
Study Type
Interventional
Intervention
controlling the MAP
Sponsored by
About this trial
This is an interventional treatment trial for Kidney Failure, Acute
Eligibility Criteria
Inclusion Criteria: Over 18 years old Intensive care patient Treated with vasopressor Given informed consent Arterial infusion A bladder catheter Exclusion Criteria: Anamneses of hypertension Neurological trauma Acute renal insufficiency other than prerenal or acute tubular necrosis etiology Hepatorenal syndrome Treated with diuretics Mechanical ventilation and unstable
Sites / Locations
- University Hospital Ghent
Outcomes
Primary Outcome Measures
creatinine clearance after 4 hours
Secondary Outcome Measures
resistance index
diuresis
urinary indices of renal function
Full Information
NCT ID
NCT00117416
First Posted
June 30, 2005
Last Updated
December 15, 2022
Sponsor
University Hospital, Ghent
1. Study Identification
Unique Protocol Identification Number
NCT00117416
Brief Title
Mean Arterial Pressure (MAP) and Renal Perfusion: Evaluation of Critically Ill Patients With Normal Creatinine or Reduced Renal Function
Official Title
MAP and Renal Perfusion: Evaluation of Critically Ill Patients With Normal Creatinine or Reduced Renal Function
Study Type
Interventional
2. Study Status
Record Verification Date
July 2021
Overall Recruitment Status
Withdrawn
Why Stopped
No subjects recruited
Study Start Date
February 2003 (undefined)
Primary Completion Date
February 2003 (undefined)
Study Completion Date
February 2003 (undefined)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Ghent
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to evaluate the renal perfusion depending on the MAP.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Kidney Failure, Acute
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Intervention Type
Procedure
Intervention Name(s)
controlling the MAP
Primary Outcome Measure Information:
Title
creatinine clearance after 4 hours
Secondary Outcome Measure Information:
Title
resistance index
Title
diuresis
Title
urinary indices of renal function
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Over 18 years old
Intensive care patient
Treated with vasopressor
Given informed consent
Arterial infusion
A bladder catheter
Exclusion Criteria:
Anamneses of hypertension
Neurological trauma
Acute renal insufficiency other than prerenal or acute tubular necrosis etiology
Hepatorenal syndrome
Treated with diuretics
Mechanical ventilation and unstable
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Eric Hoste, MD, PhD
Organizational Affiliation
University Hospital, Ghent
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital Ghent
City
Ghent
ZIP/Postal Code
9000
Country
Belgium
12. IPD Sharing Statement
Links:
URL
http://www.uzgent.be
Description
Website of the University Hospital Ghent
Learn more about this trial
Mean Arterial Pressure (MAP) and Renal Perfusion: Evaluation of Critically Ill Patients With Normal Creatinine or Reduced Renal Function
We'll reach out to this number within 24 hrs